ʻO Tilmicosin kahi antibiotic macrolide bactericidal semi-synthetic ākea i hana ʻia mai tylosin. Loaʻa iā ia kahi spectrum antibacterial e kūpono nui ana i ka Mycoplasma, Pasteurella a me Haemophilus spp. a me nā meaola Gram-positive like ʻole e like me Staphylococcus spp. Ua manaʻo ʻia e hoʻopilikia i ka synthesis protein bacteria. Ua ʻike ʻia ke kūʻē ʻana ma waena o tilmicosin a me nā antibiotic macrolide ʻē aʻe. Ma hope o ka hoʻokomo ʻana ma lalo o ka ʻili, hoʻokuʻu nui ʻia ka tilmicosin ma o ka bile i loko o nā feces, me kahi hapa liʻiliʻi e hoʻokuʻu ʻia ma o ka mimi.
Ua hōʻike ʻia ʻo Macrotyl-300 no ka mālama ʻana i nā maʻi hanu i nā bipi a me nā hipa e pili ana me Mannheimia haemolytica, Pasteurella spp. a me nā micro-organisms ʻē aʻe i hiki ke hoʻopilikia ʻia e tilmicosin, a no ka mālama ʻana i ka mastitis ovine e pili ana me Staphylococcus aureus a me Mycoplasma spp. ʻO nā hōʻailona ʻē aʻe e pili ana i ka mālama ʻana i ka interdigital necrobacillosis i nā bipi (bovine pododermatitis, foul in the foot) a me ka ovine footrot.
ʻO ka hypersensitivity a i ʻole ke kūʻē ʻana i ka tilmicosin.
ʻO ka hoʻohana like ʻana o nā macrolides ʻē aʻe, lincosamides a i ʻole ionophores.
Hoʻohana ʻia i nā ʻano lio, puaʻa a i ʻole kapena, i nā pipi e hana ana i ka waiū no ka ʻai kanaka a i ʻole i nā keiki hipa he 15 kg a emi mai paha. Hoʻohana ʻia i loko o ke kino. Mai hoʻohana i nā holoholona hānai. I ka wā hāpai, e hoʻohana wale ma hope o ka loiloi pilikia/pōmaikaʻi e ke kauka holoholona. Mai hoʻohana i nā bipi wahine i loko o 60 mau lā o ka hānau ʻana. Mai hoʻohana pū me ka adrenalin a i ʻole nā mea hoʻowalewale β-adrenergic e like me propranolol.
I kekahi manawa, hiki ke ʻike ʻia kahi pehu palupalu ma kahi i hoʻokomo ʻia ai, kahi e emi ai me ka ʻole o ka mālama hou ʻana. ʻO nā hōʻike koʻikoʻi o nā inikini he nui o nā lāʻau subcutaneous nui (150 mg/kg) i loko o nā bipi, ʻo ia hoʻi nā loli electrocardiographic haʻahaʻa i hele pū ʻia me ka necrosis myocardial focal akahai, ka edema nui o ka wahi i inikini ʻia, a me ka make. ʻO nā inikini subcutaneous hoʻokahi o 30 mg/kg i loko o nā hipa i hoʻonui i ka nui o ka hanu ʻana, a ma nā pae kiʻekiʻe (150 mg/kg) ka ataxia, ka lethargy a me ke kau ʻana o ke poʻo.
No ka inikini subcutaneous:
Pipi - niumonia: 1 ml no 30 kg ke kaumaha o ke kino (10 mg/kg).
Pipi - interdigital necrobacillosis: 0.5 ml no 30 kg ke kaumaha o ke kino (5 mg/kg).
Hipa - ka maʻi niumonia a me ka mastitis: 1 ml no 30 kg ke kaumaha o ke kino (10 mg/kg).
Hipa – footrot: 0.5 ml no 30 kg ke kaumaha o ke kino (5 mg/kg).
Nānā: E akahele loa a e hana i nā hana kūpono e pale aku ai i ka hoʻokomo ponoʻī ʻana, no ka mea, hiki i ka hoʻokomo ʻana o kēia lāʻau lapaʻau i loko o ke kanaka ke make! Pono e hāʻawi ʻia ka Macrotyl-300 e ke kauka holoholona wale nō. He mea nui ke kaupaona pololei ʻana o nā holoholona e pale aku ai i ka overdose. Pono e hōʻoia hou ʻia ka maʻi inā ʻaʻohe hoʻomaikaʻi i ʻike ʻia i loko o 48 hola. E hāʻawi hoʻokahi wale nō.
- No ka ʻiʻo:
Pipi: 60 lā.
Hipa: 42 lā.
- No ka waiū: Hipa: 15 lā.
ʻŌmole o 50 a me 100 ml.